Table 4 Adverse events associated with bevacizumab
Adverse events | Total | G1/2, n (%) | G3/4, n (%) |
|---|---|---|---|
Total | 52(33.5) | 41(26.5) | 11(7.1) |
Hypertension | 25(16.1) | 16(10.3) | 9(5.8) |
Proteinuria | 9(5.8) | 9(5.8) | 0(0) |
Epistaxis | 4(2.6) | 4(2.6) | 0(0) |
Nausea | 3(1.9) | 3(1.9) | 0(0) |
Headache | 2(1.3) | 2(1.3) | 0(0) |
Thrombogenesis | 7(4.5) | 7(4.5) | 0(0) |
Impaired wound healing | 2(1.3) | 2(1.3) | 0(0) |